Clinical Trials Logo

Parkinson Disease clinical trials

View clinical trials related to Parkinson Disease.

Filter by:

NCT ID: NCT03526991 Recruiting - Parkinson Disease Clinical Trials

Exploring the Effects of Spinal Cord Stimulation in Parkinson's Disease.

SCS for FOG
Start date: August 1, 2021
Phase: N/A
Study type: Interventional

Parkinson Disease (PD) patients experience a variety of motor issues such as walking difficulties, loss of balance, and freezing while walking, which impacts their quality of life. Some symptoms, like freezing of gait (FOG), do not respond to medications typically used to treat PD. Current surgical procedures used to alleviate PD symptoms also do not always improve FOG. Since many traditional therapies have failed for the treatment of FOG, researchers have proposed the use of newer treatments. Recent research in animal models and clinical human data using SCS has produced promising results, specifically showing improvement in FOG with the use of SCS in patients with PD. The purpose of this study is to evaluate the effectiveness of spinal cord stimulation (SCS) for the management of freezing of gait (FOG) that does not respond to conventional treatments in subjects with Parkinson's disease (PD). The investigators hypothesize that SCS significantly decreases FOG episodes in patients with PD. 1. Assess the safety, tolerability and preliminary evidence of effectiveness of upper thoracic spinal cord stimulation for freezing of gait in Parkinson's (PD) patients. 2. Explore the effects of two SCS programming paradigms on motor, nonmotor and quality of life measures in PD patients with freezing of gait.

NCT ID: NCT03523104 Recruiting - Parkinson Disease Clinical Trials

Chinese PD-LRRK2 Registry

Start date: February 1, 2017
Phase:
Study type: Observational

The purpose of the Chinese PD-LRRK2 Registry(CPD-LRRK2R) is to develop a database of patients of Parkinson's disease with leucine-rich repeat kinase 2 (LRRK2) gene variants in mainland China.

NCT ID: NCT03523065 Recruiting - Parkinson Disease Clinical Trials

Chinese PD-GBA Registry

Start date: February 1, 2017
Phase:
Study type: Observational

The purpose of the Chinese Parkinson's disease with GBA variants Registry (CPD-GBAR) is to develop a database of patients of Parkinson's disease with Glucocerebrosidase (GBA) gene variants in mainland China.

NCT ID: NCT03523052 Recruiting - Parkinson Disease Clinical Trials

Chinese PD-SNCA Registry

Start date: February 1, 2017
Phase:
Study type: Observational

The purpose of the Chinese PD-SNCA Registry(CPD-SNCAR) is to develop a database of patients of Parkinson's disease with a-synuclein (SNCA) gene variants in mainland China.

NCT ID: NCT03517059 Recruiting - Parkinson Disease Clinical Trials

Study of Dysarthria, and the Appearance of Non-dopaminergic Signs in Idiopathic PARKinson's Disease

Prodygi-II
Start date: May 11, 2017
Phase:
Study type: Observational

Pilot study: - Longitudinal follow up of the PRODY-GI cohort for parkinson's disease (PD) - Observational study of upper and lower axial symptoms' occurence in 30 PD patients in on and off drug conditions, 30 aged matched control subjects and 10 control subjects with supra nuclear palsy - Multi modal approach: functional MRI, clinical , ENT assessment, respiratory assessment, neuropsychological and gait evaluations

NCT ID: NCT03508986 Recruiting - Parkinson Disease Clinical Trials

Chinese FPD Registry

Start date: February 1, 2017
Phase:
Study type: Observational

The purpose of the Chinese Familial Parkinson's disease Registry (CFPDR) is to develop a database of patients with familial Parkinson's disease (PD) in China.

NCT ID: NCT03508960 Recruiting - Parkinson Disease Clinical Trials

Chinese EOPD Registry

Start date: February 1, 2017
Phase:
Study type: Observational

The purpose of the Chinese Early-onst Parkinson's disease Registry (CEOPDR) is to develop a database of persons with early-onset Parkinson's disease (EOPD) in China.

NCT ID: NCT03504748 Recruiting - Pain Clinical Trials

Deep rTMS in Parkinson Disease Pain Syndromes

Start date: July 20, 2015
Phase: N/A
Study type: Interventional

Pain is the most prevalent non-motor symptom in Parkinson disease, and the motor improvement not always is related to the pain improvement with the medication treatment. By this, we are testing a non-invasive method called transcranial magnetic stimulation as an alternative to treat pain related to Parkinson disease. This technique can lead to either inhibitory or excitatory effects in brain circuits depending on stimulation parameters, and is known to provide analgesic effects.

NCT ID: NCT03477695 Recruiting - Clinical trials for Parkinson's Disease and Parkinsonism

Improving Posture in Parkinson's Patients Through Home-based Training and Biofeedback

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

A stooped posture is one of the characteristic motor symptoms of patients with Parkinson's disease, and has been linked to impairments in ADL and QOL. We aimed to test the efficacy, safety, practical utility and user-friendliness of a posture correction and vibrotactile trunk angle feedback device (the UpRight) in the home setting of patients with Parkinson's disease with a stooped posture.

NCT ID: NCT03475355 Recruiting - Parkinson Disease Clinical Trials

Action Observation Theraphy in Parkinson's Disease

ACTIONPARK
Start date: April 22, 2015
Phase: N/A
Study type: Interventional

The main objective of this project is to evaluate the effectiveness of Observation of Action (Action Observation, AO) both in increasing the speed of movement of the upper limbs, agility and locomotion, and in improving the activities and quality of life in people with Parkinson's disease (PD) during a 4-6 month follow-up. The second objective is to evaluate the feasibility and effectiveness of a tele-rehabilitation protocol using home-based AO therapy. The telecommunication technology will provide a complete training through a low-cost software run on a touch-screen device, which will show the actions to be imitated several times by people with PD. This project will be the first attempt to implement AO-based treatment at home and, if successful, will be highly translational to clinical practice thanks to the advanced development and broad accessibility of information technology and telecommunications in our country. Furthermore, continuous exercise will reduce the risks of complications and the frequency of hospital admissions, thus reducing costs for the National Health System.